Healthpeak Properties (NYSE:DOC) Rating Increased to Hold at Wall Street Zen

Key Points

• Wall Street Zen upgraded Healthpeak Properties from “sell” to “hold”, adding to a mixed analyst backdrop that still leaves the stock with an overall Hold consensus and an average target price of $18.04.
• The company beat first-quarter earnings and revenue expectations, reporting $0.45 EPS versus the $0.43 estimate and $752.95 million in revenue, which was also above forecasts.
• Healthpeak Properties shares were trading at $19.61, near their 52-week high of $19.87, while institutional investors continue to hold a large stake in the REIT, owning 93.57% of the stock.

Healthpeak Properties (NYSE:DOC - Get Free Report) was upgraded by equities researchers at Wall Street Zen from a "sell" rating to a "hold" rating in a research note issued on Sunday.

Other research analysts have also recently issued reports about the stock. Robert W. Baird decreased their target price on shares of Healthpeak Properties from $20.00 to $19.00 and set an "outperform" rating for the company in a report on Monday, April 6th. Weiss Ratings reissued a "hold (c-)" rating on shares of Healthpeak Properties in a research report on Friday, April 24th. Evercore decreased their price objective on shares of Healthpeak Properties from $21.00 to $19.00 and set an "outperform" rating for the company in a report on Wednesday, February 4th. Scotiabank raised Healthpeak Properties to a "hold" rating in a research report on Thursday, April 23rd. Finally, Citigroup cut their target price on Healthpeak Properties from $18.00 to $17.50 and set a "neutral" rating on the stock in a research note on Wednesday, April 1st. Five investment analysts have rated the stock with a Buy rating and nine have given a Hold rating to the company. According to MarketBeat, Healthpeak Properties presently has an average rating of "Hold" and an average target price of $18.04.

Healthpeak Properties Price Performance

Shares of NYSE:DOC opened at $19.61 on Friday. The business has a fifty day moving average price of $17.02 and a 200-day moving average price of $17.16. The company has a debt-to-equity ratio of 1.15, a current ratio of 2.96 and a quick ratio of 2.82. The company has a market capitalization of $13.52 billion, a PE ratio of 61.28, a PEG ratio of 2.71 and a beta of 1.00. Healthpeak Properties has a 1-year low of $15.70 and a 1-year high of $19.87.

Healthpeak Properties (NYSE:DOC - Get Free Report) last announced its quarterly earnings results on Tuesday, May 5th. The real estate investment trust reported $0.45 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $0.43 by $0.02. Healthpeak Properties had a net margin of 7.73% and a return on equity of 2.61%. The company had revenue of $752.95 million for the quarter, compared to analysts' expectations of $694.59 million. During the same quarter in the previous year, the business posted $0.46 EPS. Healthpeak Properties's revenue was up 7.1% compared to the same quarter last year. Healthpeak Properties has set its FY 2026 guidance at 1.710-1.750 EPS. As a group, equities analysts expect that Healthpeak Properties will post 1.74 EPS for the current fiscal year.

Institutional Inflows and Outflows

A number of hedge funds and other institutional investors have recently added to or reduced their stakes in the stock. Norges Bank bought a new stake in Healthpeak Properties in the 4th quarter worth approximately $153,550,000. JPMorgan Chase & Co. lifted its holdings in shares of Healthpeak Properties by 41.0% during the 3rd quarter. JPMorgan Chase & Co. now owns 28,236,534 shares of the real estate investment trust's stock valued at $540,730,000 after buying an additional 8,212,504 shares during the period. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC boosted its stake in shares of Healthpeak Properties by 694.6% in the 3rd quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC now owns 8,016,692 shares of the real estate investment trust's stock worth $153,520,000 after buying an additional 7,007,777 shares during the last quarter. Bank of New York Mellon Corp boosted its stake in shares of Healthpeak Properties by 60.3% in the 1st quarter. Bank of New York Mellon Corp now owns 15,456,420 shares of the real estate investment trust's stock worth $253,949,000 after buying an additional 5,815,189 shares during the last quarter. Finally, Fuller & Thaler Asset Management Inc. grew its holdings in shares of Healthpeak Properties by 19.2% in the fourth quarter. Fuller & Thaler Asset Management Inc. now owns 29,648,260 shares of the real estate investment trust's stock worth $476,744,000 after acquiring an additional 4,776,056 shares during the period. Institutional investors own 93.57% of the company's stock.

About Healthpeak Properties

Healthpeak Properties, Inc is a real estate investment trust (REIT) specializing in healthcare-related real estate. Headquartered in Irvine, California, the company owns, develops and acquires a diversified portfolio of properties that cater to the evolving needs of the healthcare industry. Its investments span life science research facilities, medical office buildings and senior housing communities, positioning Healthpeak as a key provider of specialized real estate assets.

Within its life science segment, Healthpeak develops and leases laboratory and research space to biotechnology, pharmaceutical and other life science companies.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.